Optimizing Outcomes for Patients with Rheumatoid Arthritis
Webinar Recorded on October 15, 2020
Sponsored by Myriad Genetics, Inc.
Kroger Prescription Plans shares real-world evidence on how they integrated the Vectra test to personalize rheumatoid arthritis (RA) therapy. Novel approaches will be discussed on how to objectively measure disease activity to guide and safely stratify treatment. The American College of Rheumatology included Vectra in their recommendations for treating patients with RA.
- Kathleen Hennessey, Sr. Medical Director, Myriad Genetics
- Kevin Favro, Senior Vice President, Kroger Prescription Plans
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.